WC
AERI

Weatherbie Capital’s Aerie Pharmaceuticals AERI Stock Holding History

Weatherbie Capital’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$4.45M Sell
117,434
-265,684
-69% -$10M 0.56% 43
2016
Q3 		$14.5M Buy
383,118
+23,114
+6% +$510K 1.82% 25
2016
Q2 		$6.34M Sell
360,004
-20,186
-5% -$327K 0.9% 41
2016
Q1 		$4.62M Buy
380,190
+207,427
+120% +$3.28M 0.61% 43
2015
Q4 		$4.21M Sell
172,763
-128,530
-43% -$3M 0.49% 45
2015
Q3 		$5.34M Buy
301,293
+129,178
+75% +$2.34M 0.62% 42
2015
Q2 		$3.04M Buy
+172,115
New +$3.16M 0.31% 47

Other funds holding AERI

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Weatherbie Capital's AERI Position: Q4 2016 in Review

Weatherbie Capital reduced its Aerie Pharmaceuticals (AERI) stake by 69% in Q4 2016, selling an estimated $10M and leaving 117,434 shares worth $4.45M. The position accounts for 0.56% of the portfolio, ranked #43.

Weatherbie Capital first reported a position in AERI in Q2 2015 and has held it in 7 quarters since. The position peaked at $14.5M in Q3 2016. 151 funds tracked by Wall St. Rank hold AERI as of Q4 2016.

  • Weatherbie Capital held 117,434 shares of Aerie Pharmaceuticals worth $4.45M as of Q4 2016.
  • Weatherbie Capital sold 265,684 Aerie Pharmaceuticals shares in Q4 2016, an estimated $10M.
  • Aerie Pharmaceuticals made up 0.56% of Weatherbie Capital's portfolio in Q4 2016, its #43 holding.
  • Weatherbie Capital first reported a position in Aerie Pharmaceuticals in Q2 2015 and has held it in 7 quarters since.
  • Weatherbie Capital's Aerie Pharmaceuticals position peaked at $14.5M in Q3 2016.
  • 151 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2016.

Based on Weatherbie Capital's 13F filing for Q4 2016, filed 14 Feb 2017.